Central Garden & Pet Company CENT
39.51
0.00
0.00%
as of 25 Sep
- Market cap
- $2.2B
- P/E
- 14.6×
Follow CENT
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
12.66 | 13.02 | 13.27 | 16.42 |
P/S ratio |
0.66 | 0.64 | 0.71 | 0.88 | |
P/FCF ratio |
7.08 | 6.93 | 7.99 | 7.88 | |
P/Operating CF |
11.27 | (28.12) | (45.47) | 8.32 | |
P/B ratio |
1.30 | 1.25 | 1.37 | 1.56 | |
Price to Tangible BV |
3.54 | 3.40 | 3.41 | 3.52 | |
EV/Sales |
0.75 | 0.79 | 0.88 | 0.94 | |
EV/EBITDA |
6.95 | 7.45 | 8.02 | 8.67 | |
EV/Operating CF |
7.08 | 7.34 | 8.47 | 7.44 | |
EV/FCF |
8.08 | 8.52 | 9.84 | 8.41 | |
Quick Ratio |
2.27 | 1.91 | 2.10 | 2.61 | |
Current Ratio |
3.67 | 3.42 | 3.45 | 3.79 | |
Net Debt/EBITDA |
18.19 | 12.03 | 3.87 | 1.24 | |
Debt/Assets |
32.87% | 32.72% | 31.84% | 31.48% | |
Debt/Equity |
0.75 | 0.76 | 0.72 | 0.68 | |
Asset Turnover |
0.87 | 0.86 | 0.86 | 0.83 | |
Operating CF/Net income |
(18.63) | (10.26) | (0.62) | 3.64 | |
Capex/Depreciation |
(0.48) | (0.51) | (0.49) | (0.62) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
29.92% | 28.20% | 20.49% | 21.65% | |
Intangible Assets out of Total Assets |
0.28 | 0.27 | 0.26 | 0.26 | |
Share Based Compensation of Revenue |
0.81% | 0.78% | 0.51% | 0.71% | |
Graham Net Nets |
(0.03) | (0.05) | 0.00 | 0.03 | |
Graham Number |
38.19 | 37.77 | 40.96 | 41.56 | |
Earnings Yield |
7.90% | 7.68% | 7.53% | 6.09% | |
Free Cash Flow Yield |
14.13% | 14.43% | 12.51% | 12.68% | |
Revenue per Share |
10.75 | 10.05 | 14.76 | 14.36 | |
Operating CF per Share |
2.90 | (1.14) | (0.81) | 5.33 | |
Capex per Share |
(0.17) | (0.18) | (0.17) | (0.20) | |
Free Cash Flow per Share |
2.72 | (1.32) | (0.98) | 5.12 | |
Cash per Share |
14.24 | 12.01 | 10.91 | 16.47 | |
Shareholders Equity per Share |
25.12 | 25.66 | 26.92 | 28.43 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
25.12 | 25.66 | 26.92 | 28.43 | |
Free Cash Flow |
171.89 | (81.03) | (60.09) | 314.87 | |
Working Capital |
1,437.37 | 1,391.70 | 1,482.56 | 1,570.99 | |
Capital Expenditures |
(10.84) | (10.81) | (10.45) | (12.59) | |
Net Current Asset Value |
(64.58) | (101.77) | (5.46) | 91.65 | |
EV/EBIT |
9.41 | 10.18 | 10.73 | 11.63 | |
Capex to Sales |
0.02 | 0.02 | 0.01 | 0.01 | |
Net Profit Margin |
(1.45%) | 1.11% | 8.76% | 10.18% | |
Price to Operating Income |
8.24 | 8.28 | 8.71 | 10.90 | |
| Other line items | |||||
Average Receivables |
325.76 | 378.62 | 591.02 | 491.48 | |
Average Payables |
223.61 | 242.75 | 270.06 | 214.10 | |
Average Inventory |
740.02 | 826.03 | 803.31 | 674.96 | |
Average Assets |
3,589.54 | 3,589.64 | 3,687.57 | 3,723.64 | |
Average Common Equity |
1,571.24 | 1,547.90 | 1,597.87 | 1,668.72 |
Columns are period end dates